Blog
Featured post
Leading US health systems launch the Truveta Genome Project
The Truveta Genome Project creates the world’s largest and most diverse database to discover the science of humanity.
Top reasons Truveta Data is the best real world data for studying diabetes
In the world of healthcare, few conditions have seen as much transformation over the past decade as diabetes. With 37.3 million Americans living with diabetes, and a further 96...
Real-world prescribing of long-acting injectable cabotegravir for treatment of HIV in the United States
Adequate treatments are a crucial piece in the fight against the spread of HIV, because they can make HIV viral load undetectable in the blood and thus untransmittable. Approved...
Real-world trends in APOE genetic testing associated with lecanemab
Lecanemab received accelerated FDA approval in January 2023 and full FDA approval in July 2023. A potential side effect of the drug is brain swelling and/or small hemorrhages and...
Availability of millions of echocardiogram reports make Truveta the market leader in data for cardiovascular research
When I had the first conversations about creating Truveta, I knew technology was the answer to solving healthcare data challenges. Healthcare data traditionally has been too...
Autoimmune disease treatments: How marital status and sex impact medication adherence
Adalimumab (Humira) and etanercept (Enbrel) are high-cost specialty medications used to treat a variety of autoimmune diseases. Medication adherence is often influenced by social...
Truveta showcases the power of real-world data from EHRs at October events
October was a whirlwind month for Truveta, marked by participation in various conferences across the United States. In the span of less than 10 days, Truveta experts and...
Liver Disease Statistics & Insights: Leveraging Truveta Data for Research
Hidden under the surface of daily life, a disease often referred to as a “silent killer” is slowly taking hold over millions of Americans. While approximately 4.5M US adults have...
Truveta Data used in largest, first-of-its-kind comparative study of medical devices for treatment of pulmonary embolism
Each year, approximately 900,000 patients in the United States are affected by PE, a blood clot causing a blockage in one or more pulmonary arteries in the lungs and a leading...
Truveta community expands to more than 50 organizations
Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical centers, and research institutes to study...